The agenda features a mix of clinical updates and lively debates on provocative scientific topics in the field, including emerging concepts and therapies in multiple myeloma, lymphoma, acute and chronic lymphocytic leukemia, myeloid malignancies, and much more.

July 27-28 | Los Angeles

Available DatesRegister

Saturday July 27, 2024

  • 8:00 AM – 8:05 AM

    Welcome

    • Co-Chair
      • John LeonardMD
  • 8:05 AM – 8:20 AM

    Session 1: Debate- Chemotherapy-based Approaches Are Best for initial Therapy for Mantle Cell Lymphoma

    • Invited Speaker
      • Elizabeth BremMD
  • 8:20 AM – 8:35 AM

    Session 1: Debate- Novel, “Non-chemotherapy” Approaches are Best for Initial Therapy for Mantle Cell Lymphoma

    • Invited Speaker
      • Tycel Phillips
  • 8:35 AM – 8:45 AM

    Session 1: PANEL DISCUSSION

    • Invited Moderator
      • John LeonardMD
    • Invited Panelist
      • Elizabeth BremMD
      • Tycel Phillips
  • 8:45 AM – 9:00 AM

    Session 2: Debate-Should Older Patients with Relapsed DLBCL Receive CAR-T Cell Therapy?

    • Invited Speaker
      • Mazyar ShadmanMD
  • 9:00 AM – 9:15 AM

    Session 2: Debate-Should Older Patients with Relapsed DLBCL Receive Novel Agents?

    • Invited Speaker
      • Elizabeth BremMD
  • 9:15 AM – 9:25 AM

    Session 2: PANEL DISCUSSION

    • Invited Moderator
      • John LeonardMD
    • Invited Panelist
      • Elizabeth BremMD
      • Mazyar ShadmanMD
  • 9:25 AM – 9:55 AM

    Session 3: Reevaluating Frontline Therapy and Beyond for Hodgkin Lymphoma: Strategies for Optimal Clinical Decision-Making and Targeted Therapy Across Patient Groups

  • 9:55 AM – 10:05 AM

    Session 3: Post Session Survey and Q&A

    • Invited Moderator
      • John LeonardMD
  • 10:05 AM – 10:15 AM

    Exhibit Hall Break